Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Evofem Biosciences, Inc. (EVFM)
USD0.01
0.00 (-3.61%)
US OTC Healthcare Biotechnology
Address
12400 High Bluff Drive 92130
San Diego, CA, US
San Diego, CA, US
CEO
Saundra Pelletier
Website
evofem.com
IPO
2014-11-20
CIK 1618835 ISIN US30048L3024
Description
Evofem Biosciences, Inc. operates as a biopharmaceutical enterprise dedicated to innovating and bringing to market treatments that address critical underserved areas in women's sexual and reproductive health. Their leading commercial offering is Phexxi, a vaginal gel specifically designed as a contraceptive. Additionally, the company is actively advancing EVO100, an antimicrobial vaginal gel under development, intended to prevent the urogenital spread of both Chlamydia trachomatis and Neisseria gonorrhoeae infections in women. The company's main office is situated in San Diego, California.
Market Cap & Enterprise Value
Merger & Acquisition History
| Target company | Ticker | Date | Filing |
|---|---|---|---|
| Neothetics | NEOT | 2017-11-15 | View |
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.01
0.00 (-3.61%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
283.1K
Beta
-1.28
Float Shares
132.53M
Free Float %
100.0%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.52% | +1.52% | -24.72% | -24.72% | -27.17% | -29.47% | -27.96% | -99.64% | -100.00% | -100.00% | -100.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (9 ratings, all time)
Buy
Price Targets & DCF
Current price
0.01
Low
66.25
+828,025.0%
Consensus
66.25
+828,025.0%
Median
66.25
+828,025.0%
High
66.25
+828,025.0%
Ratings Trend (MoM)
100% Bullish
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | -1 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | — | — |
| All Time | 1 |
66.25
+828,025.0%
|
Quality scores
Altman Z-Score
-180.43
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
B-
Overall Score
3 / 5
Medium
DCF Score
5 / 5
High
ROE Score
1 / 5
Low
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
3 / 5
Medium
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+4.2% ★ Q1'26: +6.4% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+100.0% ★ Q1'26: -20,700.0% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%+0.0% Q1'26: +255.7% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%+7.1% ★ Q1'26: -508.2% (vs Q1'25)
-
ROIC Biotechnology: -16.1%— Q1'26: +223.6% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+6,557.5% Q1'26: -97.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×31.90× Q1'26: -3.66× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
446.0K
est: 1.90M (-76.5%)
|
8.24M
est: 8.08M (+2.0%)
|
16.84M
est: 33.21M (-49.3%)
|
18.22M
est: 18.57M (-1.9%)
|
19.36M
est: 124.84M (-84.5%)
|
20.18M
est: 193.32M (-89.6%)
|
241.13M
241.13M – 241.13M
+24.7% YoY
|
| EBITDA |
-141.12M
est: -1.61M (-8,677.8%)
|
-165.78M
est: -6.85M (-2,319.8%)
|
-82.08M
est: -28.15M (-191.5%)
|
-16.07M
est: -15.74M (-2.1%)
|
-6.92M
est: -78.32M (+91.2%)
|
2.07M
est: -121.29M (+101.7%)
|
-151.28M
-151.28M – -151.28M
-24.7% YoY
|
| EBIT |
-142.31M
est: -1.66M (-8,474.6%)
|
-166.80M
est: -7.07M (-2,258.6%)
|
-84.12M
est: -29.06M (-189.5%)
|
-17.85M
est: -16.25M (-9.8%)
|
-7.68M
est: -82.51M (+90.7%)
|
1.44M
est: -127.78M (+101.1%)
|
-159.37M
-159.37M – -159.37M
-24.7% YoY
|
| Net Income |
-142.31M
est: -349.97B (+100.0%)
|
-205.19M
est: -263.15B (+99.9%)
|
-76.70M
est: -95.98B (+99.9%)
|
52.98M
est: -752.38M (+107.0%)
|
-8.86M
est: -128.43B (+100.0%)
|
391.0K
est: 184.63B (-100.0%)
|
369.25B
369.25B – 369.25B
+100.0% YoY
|
| SGA |
85.37M
est: 81.51M (+4.7%)
|
137.86M
est: 347.32M (-60.3%)
|
71.51M
est: 1.43B (-95.0%)
|
26.61M
est: 798.12M (-96.7%)
|
20.74M
est: 607.92M (-96.6%)
|
17.08M
est: 941.39M (-98.2%)
|
1.17B
1.17B – 1.17B
+24.7% YoY
|
| EPS |
-3,973.23
est: -3,628.13 (-9.5%)
|
-2,962.49
est: -2,728.13 (-8.6%)
|
-164.59
est: -995.00 (+83.5%)
|
10.36
est: -7.80 (+232.8%)
|
-0.09
est: -20.00 (+99.5%)
|
0.00
est: 28.75 (-100.0%)
|
57.50
57.50 – 57.50
+100.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | B- | 3/5 | 5/5 | 1/5 | 4/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-08 | B | 3/5 | 5/5 | 1/5 | 4/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-07 | B | 3/5 | 5/5 | 1/5 | 4/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-06 | B | 3/5 | 5/5 | 1/5 | 4/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-05 | B | 3/5 | 5/5 | 1/5 | 4/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-04 | B | 3/5 | 5/5 | 1/5 | 4/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-01 | B | 3/5 | 5/5 | 1/5 | 4/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-30 | B | 3/5 | 5/5 | 1/5 | 4/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-29 | B | 3/5 | 5/5 | 1/5 | 4/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-28 | B | 3/5 | 5/5 | 1/5 | 4/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-27 | B | 3/5 | 5/5 | 1/5 | 4/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-24 | B | 3/5 | 5/5 | 1/5 | 4/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-23 | B | 3/5 | 5/5 | 1/5 | 4/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-22 | B | 3/5 | 5/5 | 1/5 | 4/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-21 | B- | 3/5 | 5/5 | 1/5 | 4/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-20 | B- | 3/5 | 5/5 | 1/5 | 4/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-17 | B- | 3/5 | 5/5 | 1/5 | 4/5 | 1/5 | 3/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-1.67M
OE per share TTM
-0.02
Owner's Yield
-200.97%
Maintenance CapEx ratio
35.57%
Maint CapEx / Avg PPE
40.5%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
38
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Heights Capital Management, Inc. | 15.57M | 9.90% | — | 15.57M | — | 15.57M | CO | Delaware | 2021-05-28 | ↗ |
| 2 | CVI Investments, Inc. | 10.00M | 5.80% | — | 10.00M | — | 10.00M | CO | Cayman Islands | 2022-02-14 | ↗ |
| 3 | Heights Capital Management, Inc. | 10.00M | 5.80% | — | 10.00M | — | 10.00M | CO | Delaware | 2022-02-14 | ↗ |
| 4 | 10 | 9.14M | 19.61% | — | — | 9.14M | — | CO | United Kingdom | 2019-10-29 | ↗ |
| 5 | LF Woodford Equity Income Fund | 7.66M | 28.80% | — | 5.19M | — | — | FI | United Kingdom | 2018-06-11 | ↗ |
| 6 | (1)Names of reporting persons. BlackRock, Inc. | 5.21M | 6.40% | 5.18M | — | 5.21M | — | HC | Delaware | 2021-02-02 | ↗ |
| 7 | Kathy Overstreet Cox | 3.92M | 9.29% | — | 3.92M | — | 3.92M | IN | United States | 2022-07-19 | ↗ |
| 8 | Neil Woodford | 3.91M | 8.30% | — | 3.91M | — | 3.91M | IN | United Kingdom | 2019-11-08 | ↗ |
| 9 | Woodford Investment Management Ltd | 3.91M | 8.30% | — | 3.91M | — | 3.91M | FI | United Kingdom | 2019-11-08 | ↗ |
| 10 | (1) BlackRock, Inc. | 3.40M | 2.30% | 3.40M | — | 3.40M | — | HC | Delaware | 2021-07-12 | ↗ |
| 11 | Schroder Investment Management Ltd. | 3.36M | 7.17% | 3.36M | — | 3.36M | — | IA | — | 2020-02-13 | ↗ |
| 12 | Domain Partners VII, L.P. | 3.09M | 22.30% | 3.09M | — | 3.09M | — | PN | Delaware | 2015-02-05 | ↗ |
| 13 | Alta Partners VIII, L.P. | 2.67M | 19.20% | — | 2.67M | — | 2.67M | PN | U.S.A. | 2015-02-12 | ↗ |
| 14 | Woodford Patient Capital Trust Plc | 1.89M | 7.20% | — | 1.89M | — | 1.89M | FI | United Kingdom | 2019-02-14 | ↗ |
| 15 | Ervington Investments Limited | 1.35M | 9.83% | — | 1.35M | — | 10.00 | CO | Cyprus | 2016-01-13 | ↗ |
| 16 | Greenleas International Holdings Ltd. | 1.35M | 9.83% | — | 1.35M | — | 10.00 | CO | British Virgin Islands | 2016-01-13 | ↗ |
| 17 | Harmony Trust Settlement | 1.35M | 9.83% | — | 1.35M | — | 10.00 | CO | Cyprus | 2016-01-13 | ↗ |
| 18 | Clarus Lifesciences III, L.P. | 1.07M | 7.90% | — | 1.07M | — | — | PN | Delaware | 2015-02-13 | ↗ |
| 19 | Clarus Ventures III GP, L.P. | 1.07M | 7.90% | — | 1.07M | — | — | PN | Delaware | 2015-02-13 | ↗ |
| 20 | Clarus Ventures III, LLC | 1.07M | 7.90% | — | 1.07M | — | — | OO | Delaware | 2015-02-13 | ↗ |
| 21 | Dennis Henner | 1.07M | 7.90% | — | 1.07M | — | — | IN | United States Citizen | 2015-02-13 | ↗ |
| 22 | Kurt Wheeler | 1.07M | 7.90% | — | 1.07M | — | — | IN | Citizen | 2015-02-13 | ↗ |
| 23 | Nicholas Galakatos | 1.07M | 7.90% | — | 1.07M | — | — | IN | United States Citizen | 2015-02-13 | ↗ |
| 24 | Nicholas Simon | 1.07M | 7.90% | — | 1.07M | — | — | IN | citizen | 2015-02-13 | ↗ |
| 25 | Robert Liptak | 1.07M | 7.90% | — | 1.07M | — | — | IN | United States Citizen | 2015-02-13 | ↗ |
| 26 | Scott Requadt | 1.07M | 7.90% | — | 1.07M | — | — | IN | United States Citizen | 2015-02-13 | ↗ |
| 27 | Craig A. Drill | 891.9K | 6.46% | — | 891.9K | — | 891.9K | IN | United States of America | 2016-05-13 | ↗ |
| 28 | Craig Drill Capital, L.L.C. | 891.9K | 6.46% | — | 891.9K | — | 891.9K | IA | United States of America | 2016-05-13 | ↗ |
| 29 | Craig Drill Capital, L.P. | 633.6K | 4.59% | — | 633.6K | — | 633.6K | PN | United States of America | 2016-05-13 | ↗ |
| 30 | OF ABOVE PERSONS ( | 625.0K | 4.60% | — | 625.0K | — | 625.0K | CO | Delaware | 2016-02-12 | ↗ |
| 31 | Craig Drill Capital II, L.P. | 258.3K | 1.87% | — | 258.3K | — | 258.3K | PN | United States of America | 2016-05-13 | ↗ |
| 32 | Morgan Stanley | 196.8K | 0.10% | — | 135.2K | — | 196.8K | HC, CO | Delaware. | 2021-09-10 | ↗ |
| 33 | Morgan Stanley Capital Services LLC | 119.9K | 0.10% | — | 119.9K | — | 119.9K | CO | Delaware. | 2021-09-10 | ↗ |
| 34 | DP VII Associates, L.P. | 48.0K | 0.30% | 48.0K | — | 48.0K | — | PN | Delaware | 2015-02-05 | ↗ |
| 35 | 2 | 1.0K | 12.00% | 1.0K | — | 1.0K | — | CO | Delaware | 2020-06-09 | ↗ |
| 36 | Investment Management Ltd | — | 0.00% | — | — | — | — | FI | United Kingdom | 2020-02-04 | ↗ |
| 37 | Todd Stewart Cox | — | 0.00% | — | — | — | — | IN | United States | 2022-08-10 | ↗ |
| 38 | Woodford | — | 0.00% | — | — | — | — | IN | United Kingdom | 2020-02-04 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Ratio by volume
0.00
Bearish
Buys
0
Sells
1
Shares acquired
—
Shares disposed
104.00
Cash buys
—
Cash sales
1.00
Net activity
-104
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-12 | Zhang Yan | Officer | S-Sale | D | Common Stock | 104 | 0.04 | 4.00 | 0 | — | ↗ |
| 2023-12-21 | Kamdar Kim P. | Director | S-Sale | D | Common Stock | 10 | 0.62 | 6.21 | 0 | — | ↗ |
| 2023-04-13 | Zhang Yan | Officer | — | D | Common Stock | 0 | 0.00 | — | 13,000 | — | ↗ |
| 2022-12-31 | PELLETIER SAUNDRA L | Director / Officer | D-Return | D | Common Stock | 50,000 | 0.00 | — | 186,722 | — | ↗ |
| 2022-12-31 | File Justin J. | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-08-02 | Yip Jenny C. | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-05-31 | Atkinson Katherine Cocca | Officer | — | D | Common Stock | 0 | 0.00 | — | 16,667 | — | ↗ |
| 2022-05-27 | PELLETIER SAUNDRA L | Officer | P-Purchase | A | Common Stock | 141,000 | 0.35 | 49.7K | 236,722 | — | ↗ |
| 2022-05-04 | Rutherford Colin | Director | A-Award | A | Stock option (right to buy) | 6,000 | 0.00 | — | 6,000 | — | ↗ |
| 2022-05-04 | Rarick Lisa Dale | Director | A-Award | A | Stock option (right to buy) | 6,000 | 2.47 | 14.8K | 6,000 | — | ↗ |
| 2022-05-04 | O'Brien Anthony Stephen | Director | A-Award | A | Stock option (right to buy) | 6,000 | 0.00 | — | 6,000 | — | ↗ |
| 2022-05-04 | Kamdar Kim P. | Director | A-Award | A | Stock option (right to buy) | 6,000 | 0.00 | — | 6,000 | — | ↗ |
| 2022-05-04 | Greer Gillian | Director | A-Award | A | Stock option (right to buy) | 6,000 | 0.00 | — | 6,000 | — | ↗ |
| 2022-02-18 | PELLETIER SAUNDRA L | Director / Officer | A-Award | A | Common Stock | 750,000 | 0.00 | — | 1,435,837 | — | ↗ |
| 2022-02-18 | Fitzpatrick Alexander A | Officer | A-Award | A | Common Stock | 300,000 | 0.00 | — | 516,422 | — | ↗ |
| 2022-02-18 | File Justin J. | Officer | A-Award | A | Common Stock | 450,000 | 0.00 | — | 810,982 | — | ↗ |
| 2021-12-31 | PELLETIER SAUNDRA L | Director / Officer | D-Return | D | Common Stock | 300,000 | 0.00 | — | 685,837 | — | ↗ |
| 2021-12-31 | Fitzpatrick Alexander A | Officer | D-Return | D | Common Stock | 120,000 | 0.00 | — | 216,422 | — | ↗ |
| 2021-12-31 | File Justin J. | Officer | D-Return | D | Common Stock | 120,000 | 0.00 | — | 360,982 | — | ↗ |
| 2021-12-20 | PELLETIER SAUNDRA L | Director / Officer | P-Purchase | A | Common Stock | 135,000 | 0.38 | 50.6K | 985,837 | — | ↗ |
| 2021-12-20 | Fitzpatrick Alexander A | Officer | P-Purchase | A | Common Stock | 25,000 | 0.39 | 9.7K | 336,422 | — | ↗ |
| 2021-12-20 | File Justin J. | Officer | P-Purchase | A | Common Stock | 40,594 | 0.37 | 15.0K | 480,982 | — | ↗ |
| 2021-07-08 | Barrans Russell | Officer | F-InKind | D | Common Stock | 19,998 | 0.98 | 19.5K | 448,554 | — | ↗ |
| 2021-06-18 | Kamdar Kim P. | Director | P-Purchase | A | Common Stock | 10,000 | 1.17 | 11.7K | 19,287 | — | ↗ |
| 2021-06-14 | O'Brien Anthony Stephen | Director | P-Purchase | A | Common Stock | 8,140 | 1.31 | 10.7K | 8,140 | — | ↗ |
| 2021-06-11 | Rarick Lisa Dale | Director | P-Purchase | A | Common Stock | 5,000 | 1.20 | 6.0K | 10,250 | — | ↗ |
| 2021-06-11 | Barrans Russell | Officer | P-Purchase | A | Common Stock | 18,180 | 1.14 | 20.7K | 468,552 | — | ↗ |
| 2021-06-10 | PELLETIER SAUNDRA L | Director / Officer | P-Purchase | A | Common Stock | 50,000 | 1.03 | 51.5K | 850,837 | — | ↗ |
| 2021-06-10 | Fitzpatrick Alexander A | Officer | P-Purchase | A | Common Stock | 10,000 | 1.03 | 10.3K | 311,422 | — | ↗ |
| 2021-06-10 | File Justin J. | Officer | P-Purchase | A | Common Stock | 24,500 | 1.03 | 25.2K | 440,388 | — | ↗ |
| 2021-05-20 | PELLETIER SAUNDRA L | Director / Officer | F-InKind | D | Common Stock | 105,300 | 0.86 | 90.6K | 800,837 | — | ↗ |
| 2021-05-20 | Fitzpatrick Alexander A | Officer | F-InKind | D | Common Stock | 42,120 | 0.86 | 36.2K | 301,422 | — | ↗ |
| 2021-05-20 | File Justin J. | Officer | F-InKind | D | Common Stock | 42,280 | 0.86 | 36.4K | 415,888 | — | ↗ |
| 2021-05-20 | Culwell Kelly | Officer | F-InKind | D | Common Stock | 42,061 | 0.86 | 36.2K | 273,390 | — | ↗ |
| 2021-05-20 | Barrans Russell | Officer | F-InKind | D | Common Stock | 31,480 | 0.86 | 27.1K | 450,372 | — | ↗ |
| 2021-05-12 | Rutherford Colin | Director | A-Award | A | Stock option (right to buy) | 90,000 | 1.25 | 112.5K | 90,000 | — | ↗ |
| 2021-05-12 | Rarick Lisa Dale | Director | A-Award | A | Stock option (right to buy) | 90,000 | 1.25 | 112.5K | 90,000 | — | ↗ |
| 2021-05-12 | O'Brien Anthony Stephen | Director | A-Award | A | Common Stock | 90,000 | 1.25 | 112.5K | 90,000 | — | ↗ |
| 2021-05-12 | Kamdar Kim P. | Director | A-Award | A | Stock option (right to buy) | 90,000 | 1.25 | 112.5K | 90,000 | — | ↗ |
| 2021-05-12 | Hall William Walmsley | Director | A-Award | A | Stock option (right to buy) | 90,000 | 1.25 | 112.5K | 90,000 | — | ↗ |
| 2021-05-12 | Greer Gillian | Director | A-Award | A | Stock option (right to buy) | 90,000 | 1.25 | 112.5K | 90,000 | — | ↗ |
| 2021-03-09 | PELLETIER SAUNDRA L | Director / Officer | P-Purchase | A | Common Stock | 45,249 | 2.28 | 103.2K | 906,137 | — | ↗ |
| 2021-02-03 | PELLETIER SAUNDRA L | Director / Officer | A-Award | A | Stock option (right to buy) | 700,000 | 3.25 | 2.28M | 700,000 | — | ↗ |
| 2021-02-03 | Fitzpatrick Alexander A | Officer | A-Award | A | Common Stock | 200,000 | 0.00 | — | 343,542 | — | ↗ |
| 2021-02-03 | File Justin J. | Officer | A-Award | A | Common Stock | 200,000 | 0.00 | — | 458,168 | — | ↗ |
| 2021-02-03 | Culwell Kelly | Officer | A-Award | A | Stock option (right to buy) | 150,000 | 3.25 | 487.5K | 150,000 | — | ↗ |
| 2021-02-03 | Barrans Russell | Officer | A-Award | A | Stock option (right to buy) | 150,000 | 3.25 | 487.5K | 150,000 | — | ↗ |
| 2020-11-17 | Fitzpatrick Alexander A | Officer | P-Purchase | A | Common Stock | 9,090 | 2.20 | 20.0K | 143,542 | — | ↗ |
| 2020-11-17 | File Justin J. | Officer | P-Purchase | A | Common Stock | 7,760 | 2.17 | 16.8K | 258,168 | — | ↗ |
| 2020-09-11 | Barrans Russell | Officer | P-Purchase | A | Common Stock | 3,000 | 2.08 | 6.2K | 279,052 | — | ↗ |
| 2020-09-10 | Barrans Russell | Officer | P-Purchase | A | Common Stock | 1,000 | 2.71 | 2.7K | 276,052 | — | ↗ |
| 2020-09-08 | PELLETIER SAUNDRA L | Director / Officer | S-Sale | D | Common Stock | 122,500 | 3.26 | 399.4K | 360,888 | — | ↗ |
| 2020-07-08 | Barrans Russell | Officer | F-InKind | D | Common Stock | 20,381 | 3.30 | 67.3K | 275,052 | — | ↗ |
| 2020-06-17 | Rarick Lisa Dale | Director | P-Purchase | A | Common Stock | 5,250 | 2.99 | 15.7K | 5,250 | — | ↗ |
| 2020-06-15 | Hall William Walmsley | Director | P-Purchase | A | Common Stock | 5,000 | 2.85 | 14.3K | 5,000 | — | ↗ |
| 2020-06-12 | Kamdar Kim P. | Director / 10% Owner | P-Purchase | A | Common Stock | 5,000 | 2.94 | 14.7K | 9,287 | — | ↗ |
| 2020-06-12 | File Justin J. | Officer | P-Purchase | A | Common Stock | 8,500 | 3.14 | 26.7K | 250,408 | — | ↗ |
| 2020-06-05 | PELLETIER SAUNDRA L | Director / Officer | F-InKind | D | Common Stock | 85,620 | 3.31 | 283.4K | 479,085 | — | ↗ |
| 2020-06-05 | Invesco Ltd. | 10% Owner | P-Purchase | A | Common stock | 857,143 | 3.50 | 3.00M | 13,226,532 | — | ↗ |
| 2020-06-05 | Fitzpatrick Alexander A | Officer | F-InKind | D | Common Stock | 31,590 | 3.31 | 104.6K | 134,452 | — | ↗ |
| 2020-06-05 | File Justin J. | Officer | F-InKind | D | Common Stock | 42,810 | 3.31 | 141.7K | 237,605 | — | ↗ |
| 2020-06-05 | Culwell Kelly | Officer | F-InKind | D | Common Stock | 31,548 | 3.31 | 104.4K | 115,451 | — | ↗ |
| 2020-06-05 | Barrans Russell | Officer | F-InKind | D | Common Stock | 15,455 | 3.31 | 51.2K | 293,509 | — | ↗ |
| 2020-06-04 | Link Fund Solutions Ltd | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per share | 9,138,504 | 0.23 | 2.10M | 0 | — | ↗ |
| 2020-06-04 | ACACIA RESEARCH CORP | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per share | 9,138,504 | 3.21 | 29.33M | 1,000 | — | ↗ |
| 2020-05-26 | Invesco Ltd. | 10% Owner | S-Sale | D | Common stock | 73,814 | 5.79 | 427.4K | 12,369,454 | — | ↗ |
| 2020-05-22 | PELLETIER SAUNDRA L | Director / Officer | F-InKind | D | Common Stock | 84,525 | 4.99 | 421.8K | 564,705 | — | ↗ |
| 2020-05-22 | Fitzpatrick Alexander A | Officer | F-InKind | D | Common Stock | 39,487 | 4.99 | 197.0K | 166,042 | — | ↗ |
| 2020-05-22 | File Justin J. | Officer | F-InKind | D | Common Stock | 42,262 | 4.99 | 210.9K | 280,415 | — | ↗ |
| 2020-05-22 | Culwell Kelly | Officer | F-InKind | D | Common Stock | 39,435 | 4.99 | 196.8K | 146,999 | — | ↗ |
| 2020-05-22 | Barrans Russell | Officer | F-InKind | D | Common Stock | 19,474 | 4.99 | 97.2K | 308,964 | — | ↗ |
| 2020-05-21 | PDL BIOPHARMA, INC. | 10% Owner | J-Other | D | Common Stock | 13,333,334 | 0.00 | — | 0 | — | ↗ |
| 2020-05-15 | Invesco Ltd. | 10% Owner | S-Sale | D | Common stock | 3,211 | 5.04 | 16.2K | 12,443,268 | — | ↗ |
| 2020-05-14 | Invesco Ltd. | 10% Owner | J-Other | A | Common stock | 78,013 | 5.13 | 400.2K | 12,446,479 | — | ↗ |
| 2020-05-12 | Rutherford Colin | Director | A-Award | A | Stock option (right to buy) | 50,000 | 5.06 | 253.0K | 50,000 | — | ↗ |
| 2020-05-12 | Rarick Lisa Dale | Director | A-Award | A | Stock option (right to buy) | 50,000 | 5.06 | 253.0K | 50,000 | — | ↗ |
| 2020-05-12 | O'Brien Anthony Stephen | Director | A-Award | A | Common Stock | 50,000 | 5.06 | 253.0K | 50,000 | — | ↗ |
| 2020-05-12 | Kamdar Kim P. | Director / 10% Owner | A-Award | A | Stock option (right to buy) | 50,000 | 5.06 | 253.0K | 50,000 | — | ↗ |
| 2020-05-12 | Hall William Walmsley | Director | A-Award | A | Stock option (right to buy) | 50,000 | 5.06 | 253.0K | 50,000 | — | ↗ |
| 2020-05-12 | Greer Gillian | Director | A-Award | A | Stock option (right to buy) | 50,000 | 5.06 | 253.0K | 50,000 | — | ↗ |
| 2020-05-06 | PELLETIER SAUNDRA L | Director / Officer | F-InKind | D | Common Stock | 16,905 | 5.24 | 88.6K | 649,230 | — | ↗ |
| 2020-05-06 | Fitzpatrick Alexander A | Officer | F-InKind | D | Common Stock | 7,802 | 5.24 | 40.9K | 205,529 | — | ↗ |
| 2020-05-06 | File Justin J. | Officer | F-InKind | D | Common Stock | 8,420 | 5.24 | 44.1K | 322,677 | — | ↗ |
| 2020-05-06 | Culwell Kelly | Officer | F-InKind | D | Common Stock | 7,792 | 5.24 | 40.8K | 186,434 | — | ↗ |
| 2020-05-06 | Barrans Russell | Officer | F-InKind | D | Common Stock | 3,802 | 5.24 | 19.9K | 328,438 | — | ↗ |
| 2020-05-01 | Culwell Kelly | Officer | S-Sale | D | Common Stock | 1,000 | 4.75 | 4.8K | 194,226 | — | ↗ |
| 2020-04-30 | Culwell Kelly | Officer | S-Sale | D | Common Stock | 1,000 | 4.66 | 4.7K | 195,226 | — | ↗ |
| 2020-04-01 | Lynch Thomas G | Director | A-Award | A | Restricted Stock Units | 150,000 | 0.00 | — | 150,000 | — | ↗ |
| 2020-03-31 | Lynch Thomas G | Director | M-Exempt | A | Common Stock | 37,500 | 0.00 | — | 325,000 | — | ↗ |
| 2020-02-25 | Rarick Lisa Dale | Director | A-Award | A | Stock option (right to buy) | 75,000 | 5.85 | 438.8K | 75,000 | — | ↗ |
| 2020-02-19 | Culwell Kelly | Officer | S-Sale | D | Common Stock | 1,000 | 7.00 | 7.0K | 196,226 | — | ↗ |
| 2020-02-19 | Barrans Russell | Officer | S-Sale | D | Common Stock | 14,957 | 6.50 | 97.2K | 332,240 | — | ↗ |
| 2020-02-05 | PELLETIER SAUNDRA L | Director / Officer | A-Award | A | Stock option (right to buy) | 300,000 | 4.87 | 1.46M | 300,000 | — | ↗ |
| 2020-02-05 | Fitzpatrick Alexander A | Officer | A-Award | A | Stock option (right to buy) | 100,000 | 4.87 | 487.0K | 100,000 | — | ↗ |
| 2020-02-05 | File Justin J. | Officer | A-Award | A | Stock option (right to buy) | 100,000 | 4.87 | 487.0K | 100,000 | — | ↗ |
| 2020-02-05 | Culwell Kelly | Officer | A-Award | A | Common Stock | 3,688 | 5.21 | 19.2K | 47,226 | — | ↗ |
| 2020-02-05 | Barrans Russell | Officer | A-Award | A | Stock option (right to buy) | 100,000 | 4.87 | 487.0K | 100,000 | — | ↗ |
| 2020-01-16 | Barrans Russell | Officer | S-Sale | D | Common Stock | 1,578 | 6.50 | 10.3K | 196,298 | — | ↗ |
| 2020-01-13 | PELLETIER SAUNDRA L | Director / Officer | S-Sale | D | Common Stock | 3,295 | 6.00 | 19.8K | 362,289 | — | ↗ |
| 2020-01-13 | File Justin J. | Officer | S-Sale | D | Common Stock | 1,648 | 6.00 | 9.9K | 177,251 | — | ↗ |
| 2020-01-02 | PELLETIER SAUNDRA L | Director / Officer | S-Sale | D | Common Stock | 6,705 | 6.05 | 40.6K | 365,584 | — | ↗ |
| 2020-01-02 | File Justin J. | Officer | S-Sale | D | Common Stock | 3,352 | 6.05 | 20.3K | 178,899 | — | ↗ |
| 2019-12-31 | Lynch Thomas G | Director | M-Exempt | A | Common Stock | 37,500 | 0.00 | — | 287,500 | — | ↗ |
| 2019-12-02 | PELLETIER SAUNDRA L | Director / Officer | S-Sale | D | Common Stock | 20,000 | 7.30 | 146.0K | 372,289 | — | ↗ |
| 2019-12-02 | File Justin J. | Officer | S-Sale | D | Common Stock | 10,000 | 7.16 | 71.6K | 182,251 | — | ↗ |
| 2019-12-02 | Culwell Kelly | Officer | S-Sale | D | Common Stock | 1,000 | 7.35 | 7.4K | 43,538 | — | ↗ |
| 2019-11-25 | PELLETIER SAUNDRA L | Director / Officer | F-InKind | D | Common Stock | 22,387 | 6.22 | 139.2K | 392,289 | — | ↗ |
| 2019-11-25 | Fitzpatrick Alexander A | Officer | F-InKind | D | Common Stock | 7,747 | 6.22 | 48.2K | 63,331 | — | ↗ |
| 2019-11-25 | File Justin J. | Officer | F-InKind | D | Common Stock | 10,102 | 6.22 | 62.8K | 192,251 | — | ↗ |
| 2019-11-25 | Culwell Kelly | Officer | F-InKind | D | Common Stock | 5,187 | 6.22 | 32.3K | 44,538 | — | ↗ |
| 2019-11-25 | Barrans Russell | Officer | F-InKind | D | Common Stock | 9,277 | 6.22 | 57.7K | 197,876 | — | ↗ |
| 2019-11-21 | PELLETIER SAUNDRA L | Director / Officer | S-Sale | D | Common Stock | 10,000 | 6.01 | 60.1K | 414,676 | — | ↗ |
| 2019-11-21 | File Justin J. | Officer | S-Sale | D | Common Stock | 4,900 | 6.00 | 29.4K | 202,353 | — | ↗ |
| 2019-11-20 | PELLETIER SAUNDRA L | Director / Officer | F-InKind | D | Common Stock | 22,657 | 5.74 | 130.1K | 424,676 | — | ↗ |
| 2019-11-20 | Fitzpatrick Alexander A | Officer | F-InKind | D | Common Stock | 7,747 | 5.74 | 44.5K | 71,078 | — | ↗ |
| 2019-11-20 | File Justin J. | Officer | S-Sale | D | Common Stock | 100 | 6.00 | 600.00 | 207,253 | — | ↗ |
| 2019-11-20 | Culwell Kelly | Officer | F-InKind | D | Common Stock | 5,187 | 5.74 | 29.8K | 49,725 | — | ↗ |
| 2019-11-20 | Barrans Russell | Officer | F-InKind | D | Common Stock | 9,044 | 5.74 | 51.9K | 207,153 | — | ↗ |
| 2019-10-16 | Fitzpatrick Alexander A | Officer | F-InKind | D | Common Stock | 18,427 | 5.01 | 92.3K | 78,825 | — | ↗ |
| 2019-10-15 | Link Fund Solutions Ltd | 10% Owner | — | I | Common Stock, par value $0.0001 per share | 0 | 0.00 | — | 9,087,206 | — | ↗ |
| 2019-10-11 | PDL BIOPHARMA, INC. | 10% Owner | — | D | Warrants | 1,666,667 | 6.38 | 10.63M | 0 | — | ↗ |
| 2019-09-30 | Lynch Thomas G | Director | M-Exempt | A | Common Stock | 37,500 | 0.00 | — | 250,000 | — | ↗ |
| 2019-08-22 | PELLETIER SAUNDRA L | Director / Officer | F-InKind | D | Common Stock | 4,923 | 5.13 | 25.3K | 447,333 | — | ↗ |
| 2019-08-22 | Fitzpatrick Alexander A | Officer | F-InKind | D | Common Stock | 1,296 | 5.13 | 6.6K | 97,252 | — | ↗ |
| 2019-08-22 | File Justin J. | Officer | F-InKind | D | Common Stock | 1,558 | 5.13 | 8.0K | 217,455 | — | ↗ |
| 2019-08-22 | Culwell Kelly | Officer | F-InKind | D | Common Stock | 864 | 5.13 | 4.4K | 54,912 | — | ↗ |
| 2019-08-22 | Barrans Russell | Officer | F-InKind | D | Common Stock | 962 | 5.13 | 4.9K | 216,197 | — | ↗ |
| 2019-07-08 | Barrans Russell | Officer | F-InKind | D | Common Stock | 13,257 | 4.99 | 66.2K | 217,159 | — | ↗ |
| 2019-06-30 | Lynch Thomas G | Director | M-Exempt | A | Common Stock | 37,500 | 0.00 | — | 212,500 | — | ↗ |
| 2019-06-10 | PELLETIER SAUNDRA L | Director / Officer | F-InKind | D | Common Stock | 35,826 | 6.36 | 227.9K | 452,256 | — | ↗ |
| 2019-06-10 | PDL BIOPHARMA, INC. | 10% Owner | P-Purchase | A | Common Stock | 6,666,667 | 4.50 | 30.00M | 13,333,334 | — | ↗ |
| 2019-06-10 | Monnet Dominique | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-06-10 | Invesco Ltd. | 10% Owner | P-Purchase | A | Common stock | 2,222,222 | 4.50 | 10.00M | 11,812,910 | — | ↗ |
| 2019-06-10 | Fitzpatrick Alexander A | Officer | F-InKind | D | Common Stock | 7,777 | 6.36 | 49.5K | 98,548 | — | ↗ |
| 2019-06-10 | File Justin J. | Officer | F-InKind | D | Common Stock | 10,185 | 6.36 | 64.8K | 219,013 | — | ↗ |
| 2019-06-10 | Culwell Kelly | Officer | F-InKind | D | Common Stock | 5,187 | 6.36 | 33.0K | 55,776 | — | ↗ |
| 2019-06-10 | Barrans Russell | Officer | F-InKind | D | Common Stock | 5,965 | 6.36 | 37.9K | 80,416 | — | ↗ |
| 2019-06-05 | Rutherford Colin | Director | A-Award | A | Stock option (right to buy) | 50,000 | 6.05 | 302.5K | 50,000 | — | ↗ |
| 2019-06-05 | O'Brien Anthony Stephen | Director | A-Award | A | Common Stock | 50,000 | 6.05 | 302.5K | 50,000 | — | ↗ |
| 2019-06-05 | Kamdar Kim P. | Director | A-Award | A | Stock Option (Right to Buy) | 50,000 | 6.05 | 302.5K | 50,000 | — | ↗ |
| 2019-06-05 | Hall William Walmsley | Director | A-Award | A | Stock option (right to buy) | 50,000 | 6.05 | 302.5K | 50,000 | — | ↗ |
| 2019-06-05 | Greer Gillian | Director | A-Award | A | Stock option (right to buy) | 50,000 | 6.05 | 302.5K | 50,000 | — | ↗ |
| 2019-05-22 | Kamdar Kim P. | Director | J-Other | A | Common Stock | 4,287 | 0.00 | — | 4,287 | — | ↗ |
| 2019-05-21 | Kamdar Kim P. | Director | S-Sale | D | Common Stock | 655 | 5.07 | 3.3K | 0 | — | ↗ |
| 2019-04-11 | PDL BIOPHARMA, INC. | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 6,666,667 | — | ↗ |
| 2019-04-10 | Invesco Ltd. | 10% Owner | J-Other | A | Right to Purchase | 555,556 | 6.38 | 3.54M | 2,777,778 | — | ↗ |
| 2019-04-01 | PELLETIER SAUNDRA L | Director / Officer | F-InKind | D | Common Stock | 3,731 | 3.55 | 13.2K | 488,082 | — | ↗ |
| 2019-04-01 | Lynch Thomas G | Director | A-Award | A | Restricted Stock Units | 150,000 | 0.00 | — | 150,000 | — | ↗ |
| 2019-04-01 | Fitzpatrick Alexander A | Officer | F-InKind | D | Common Stock | 1,298 | 3.55 | 4.6K | 106,325 | — | ↗ |
| 2019-04-01 | File Justin J. | Officer | F-InKind | D | Common Stock | 1,292 | 3.55 | 4.6K | 229,198 | — | ↗ |
| 2019-04-01 | Culwell Kelly | Officer | F-InKind | D | Common Stock | 1,022 | 3.55 | 3.6K | 60,963 | — | ↗ |
| 2019-04-01 | Barrans Russell | Officer | F-InKind | D | Common Stock | 1,160 | 3.55 | 4.1K | 86,381 | — | ↗ |
| 2019-02-25 | PELLETIER SAUNDRA L | Director / Officer | A-Award | A | Common Stock | 150,000 | 0.00 | — | 491,813 | — | ↗ |
| 2019-02-25 | Fitzpatrick Alexander A | Officer | A-Award | A | Common Stock | 50,000 | 0.00 | — | 107,623 | — | ↗ |
| 2019-02-25 | File Justin J. | Officer | A-Award | A | Common Stock | 50,000 | 0.00 | — | 230,490 | — | ↗ |
| 2019-02-25 | Culwell Kelly | Officer | A-Award | A | Common Stock | 50,000 | 0.00 | — | 61,985 | — | ↗ |
| 2019-02-25 | Barrans Russell | Officer | A-Award | A | Common Stock | 75,000 | 0.00 | — | 87,541 | — | ↗ |
| 2019-02-08 | Invesco Ltd. | 10% Owner | P-Purchase | A | Common stock | 425,531 | 2.64 | 1.12M | 9,590,688 | — | ↗ |
| 2018-11-28 | PELLETIER SAUNDRA L | Director / Officer | A-Award | A | Stock option (right to buy) | 0 | 3.45 | — | 284,625 | — | ↗ |
| 2018-11-28 | Fitzpatrick Alexander A | Officer | A-Award | A | Stock option (right to buy) | 0 | 3.45 | — | 100,000 | — | ↗ |
| 2018-11-28 | File Justin J. | Officer | A-Award | A | Stock option (right to buy) | 0 | 3.45 | — | 103,500 | — | ↗ |
| 2018-11-28 | Culwell Kelly | Officer | A-Award | A | Common Stock | 0 | 3.45 | — | 100,000 | — | ↗ |
| 2018-11-28 | Barrans Russell | Officer | A-Award | A | Stock option (right to buy) | 0 | 3.45 | — | 100,000 | — | ↗ |
| 2018-11-21 | Barrans Russell | Officer | P-Purchase | A | Common Stock | 279 | 3.55 | 990.45 | 12,820 | — | ↗ |
| 2018-10-16 | Fitzpatrick Alexander A | Officer | F-InKind | D | Common Stock | 17,377 | 3.78 | 65.7K | 57,623 | — | ↗ |
| 2018-08-21 | Fitzpatrick Alexander A | Officer | P-Purchase | A | Common Stock | 500 | 2.27 | 1.1K | 75,000 | — | ↗ |
| 2018-08-20 | Fitzpatrick Alexander A | Officer | P-Purchase | A | Common Stock | 4,500 | 2.20 | 9.9K | 74,500 | — | ↗ |
| 2018-08-16 | Culwell Kelly | Officer | P-Purchase | A | Common Stock | 3,000 | 2.24 | 6.7K | 11,985 | — | ↗ |
| 2018-08-15 | Lynch Thomas G | Director | P-Purchase | A | Common Stock | 68,929 | 2.33 | 160.6K | 175,000 | — | ↗ |
| 2018-08-14 | Lynch Thomas G | Director | P-Purchase | A | Common Stock | 31,071 | 2.10 | 65.2K | 106,071 | — | ↗ |
| 2018-08-10 | PELLETIER SAUNDRA L | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 2.11 | 21.1K | 341,813 | — | ↗ |
| 2018-08-10 | Barrans Russell | Officer | P-Purchase | A | Common Stock | 3,715 | 1.98 | 7.4K | 12,541 | — | ↗ |
| 2018-07-31 | Rutherford Colin | Director | A-Award | A | Stock option (right to buy) | 0 | 2.10 | — | 5,550 | — | ↗ |
| 2018-07-31 | PELLETIER SAUNDRA L | Director / Officer | A-Award | A | Stock option (right to buy) | 0 | 2.10 | — | 313,500 | — | ↗ |
| 2018-07-31 | Lynch Thomas G | Director | A-Award | A | Stock option (right to buy) | 0 | 2.10 | — | 85,500 | — | ↗ |
| 2018-07-31 | Fitzpatrick Alexander A | Officer | A-Award | A | Stock option (right to buy) | 0 | 2.10 | — | 104,500 | — | ↗ |
| 2018-07-31 | File Justin J. | Officer | A-Award | A | Stock option (right to buy) | 0 | 2.10 | — | 114,000 | — | ↗ |
| 2018-07-31 | Culwell Kelly | Officer | A-Award | A | Common Stock | 98,800 | 2.10 | 207.5K | 98,800 | — | ↗ |
| 2018-07-31 | Barrans Russell | Officer | A-Award | A | Stock option (right to buy) | 98,800 | 2.10 | 207.5K | 98,800 | — | ↗ |
| 2018-07-24 | O'Brien Anthony Stephen | Director | A-Award | A | Common Stock | 12,875 | 2.31 | 29.7K | 12,875 | — | ↗ |
| 2018-07-02 | PELLETIER SAUNDRA L | Director / Officer | F-InKind | D | Common Stock | 493,187 | 2.46 | 1.21M | 331,813 | — | ↗ |
| 2018-07-02 | Lynch Thomas G | Director | M-Exempt | A | Common Stock | 75,000 | 0.00 | — | 75,000 | — | ↗ |
| 2018-07-02 | Fitzpatrick Alexander A | Officer | A-Award | A | Common Stock | 70,000 | 0.00 | — | 70,000 | — | ↗ |
| 2018-07-02 | File Justin J. | Officer | F-InKind | D | Common Stock | 119,510 | 2.46 | 294.0K | 180,490 | — | ↗ |
| 2018-07-02 | Culwell Kelly | Officer | A-Award | A | Common Stock | 13,733 | 0.00 | — | 13,733 | — | ↗ |
| 2018-07-02 | Barrans Russell | Officer | F-InKind | D | Common Stock | 2,840 | 2.46 | 7.0K | 8,826 | — | ↗ |
| 2018-05-22 | Invesco Ltd. | 10% Owner | P-Purchase | A | Common stock, Par value $0.0001 per share | 2,127,659 | 4.69 | 9.98M | 9,165,157 | — | ↗ |
| 2018-05-08 | Rutherford Colin | Director | A-Award | A | Stock option (right to buy) | 12,875 | 6.99 | 90.0K | 12,875 | — | ↗ |
| 2018-05-08 | Lynch Thomas G | Director | A-Award | A | Stock option (right to buy) | 12,875 | 6.99 | 90.0K | 12,875 | — | ↗ |
| 2018-05-08 | Kamdar Kim P. | Director | A-Award | A | Stock Option (Right to Buy) | 12,875 | 6.99 | 90.0K | 12,875 | — | ↗ |
| 2018-05-08 | Hall William Walmsley | Director | A-Award | A | Stock option (right to buy) | 12,875 | 6.99 | 90.0K | 12,875 | — | ↗ |
| 2018-05-08 | Greer Gillian | Director | A-Award | A | Stock option (right to buy) | 12,875 | 6.99 | 90.0K | 12,875 | — | ↗ |
| 2018-03-12 | Rutherford Colin | Director | A-Award | A | Stock option (right to buy) | 15,000 | 7.29 | 109.4K | 15,000 | — | ↗ |
| 2018-03-12 | PELLETIER SAUNDRA L | Director / Officer | A-Award | A | Stock option (right to buy) | 825,000 | 7.29 | 6.01M | 825,000 | — | ↗ |
| 2018-03-12 | O'Brien Anthony Stephen | Director | A-Award | A | Stock option (right to buy) | 24,691 | 7.29 | 180.0K | 24,691 | — | ↗ |
| 2018-03-12 | Lynch Thomas G | Director | A-Award | A | Stock option (right to buy) | 24,691 | 7.29 | 180.0K | 24,691 | — | ↗ |
| 2018-03-12 | Hall William Walmsley | Director | A-Award | A | Stock option (right to buy) | 24,691 | 7.29 | 180.0K | 24,691 | — | ↗ |
| 2018-03-12 | Greer Gillian | Director | A-Award | A | Stock option (right to buy) | 24,691 | 7.29 | 180.0K | 24,691 | — | ↗ |
| 2018-03-12 | Fitzpatrick Alexander A | Officer | A-Award | A | Stock option (right to buy) | 275,000 | 7.29 | 2.00M | 275,000 | — | ↗ |
| 2018-03-12 | File Justin J. | Officer | A-Award | A | Stock option (right to buy) | 300,000 | 7.29 | 2.19M | 300,000 | — | ↗ |
Executive team
Top executives
EBIT / Employee
45.0K
Shares Outstanding
132.53M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Saundra Pelletier, Chief Executive Officer | 100.00 | 579.8K | — | — | — | — | 579.9K | 0.00% | ↗ |
| 2 | 2024 | Ivy Zhang, Chief Financial Officer and Secretary | 75.00 | 243.8K | — | — | — | — | 243.8K | 0.00% | ↗ |
| 3 | 2023 | Saundra Pelletier, Chief Executive Officer | 100.00 | 455.2K | — | — | — | — | 455.3K | 0.00% | ↗ |
| 4 | 2023 | Ivy Zhang, Chief Financial Officer and Secretary | 50.00 | 94.4K | — | — | — | — | 94.5K | 0.00% | ↗ |
| 5 | 2022 | Saundra Pelletier, Chief Executive Officer | — | 203.0K | — | — | — | — | 203.0K | 0.00% | ↗ |
| 6 | 2021 | Saundra Pelletier, Chief Executive Officer | — | 402.0K | — | — | — | — | 402.0K | 0.00% | ↗ |
| 7 | 2021 | Justin J. File, Chief Financial Officer | 41.00 | 218.8K | — | — | — | — | 218.8K | 0.00% | ↗ |
| 8 | 2021 | Alex Fitzpatrick, General Counsel | 28.00 | 116.2K | — | — | — | — | 116.2K | 0.00% | ↗ |
| 9 | 2020 | Saundra Pelletier Chief Executive Officer | 780.9K | 1.05M | 1.30M | 1.04M | — | 14.7K | 4.19M | 56.03% | ↗ |
| 10 | 2020 | Justin J. File Chief Financial Officer | 566.6K | 444.9K | 651.5K | 348.0K | — | 3.1K | 2.01M | 49.62% | ↗ |
| 11 | 2020 | Russ Barrans Chief Commercial Officer | 491.6K | 265.8K | 816.5K | 348.0K | — | 5.5K | 1.93M | 60.41% | ↗ |
| 12 | 2020 | Saundra Pelletier, Chief Executive Officer | 100.00 | 1.05M | — | — | — | — | 1.05M | 0.00% | ↗ |
| 13 | 2020 | Justin J. File, Chief Financial Officer | 75.00 | 444.9K | — | — | — | — | 445.0K | 0.00% | ↗ |
| 14 | 2020 | Alex Fitzpatrick, General Counsel | 50.00 | 225.6K | — | — | — | — | 225.7K | 0.00% | ↗ |
| 15 | 2019 | Saundra Pelletier Chief Executive Officer | 846.6K | 1.04M | 889.5K | — | — | 23.5K | 2.80M | 31.72% | ↗ |
| 16 | 2019 | Russ Barrans Chief Commercial Officer | 478.0K | 197.0K | 694.3K | — | — | 3.6K | 1.37M | 50.57% | ↗ |
| 17 | 2019 | Russell Barrans Chief Commercial Officer | 478.0K | 197.0K | 694.3K | — | — | 3.6K | 1.37M | 50.57% | ↗ |
| 18 | 2019 | Justin J. File Chief Financial Officer | 611.8K | 273.7K | 296.5K | — | — | 994.00 | 1.18M | 25.06% | ↗ |
| 19 | 2018 | Saundra Pelletier Chief Executive Officer | 738.4K | 1.02M | 2.03M | 4.50M | — | 6.9K | 8.30M | 78.74% | ↗ |
| 20 | 2018 | Justin J. File Chief Financial Officer | 578.5K | 344.4K | 738.0K | 1.64M | — | 810.00 | 3.30M | 72.01% | ↗ |
| 21 | 2018 | Kelly Culwell, M.D. Chief Medical Officer | 447.0K | 199.9K | 33.8K | 1.42M | — | 810.00 | 2.10M | 69.17% | ↗ |
| 22 | 2018 | Russell Barrans Chief Commercial Officer | 395.2K | 170.6K | 28.7K | 1.42M | — | 2.3K | 2.02M | 71.83% | ↗ |
| 23 | 2018 | Susan A. Knudson Former Chief Financial Officer | 63.0K | 245.1K | — | — | — | 341.9K | 650.0K | 0.00% | ↗ |
| 24 | 2017 | Saundra Pelletier Chief Executive Officer | 731.4K | 922.7K | — | — | — | 810.00 | 1.65M | 0.00% | ↗ |
| 25 | 2017 | Justin J. File Chief Financial Officer | 562.4K | 306.8K | — | — | — | 810.00 | 869.9K | 0.00% | ↗ |
| 26 | 2017 | Susan A. Knudson Former Chief Financial Officer | 317.0K | 190.2K | — | 130.1K | — | 1.0K | 638.3K | 20.38% | ↗ |
| 27 | 2017 | Maria Feldman Former Vice President, Clinical Research, Operations, Regulatory and Quality | 274.0K | 137.0K | — | 197.8K | — | 539.00 | 609.3K | 32.46% | ↗ |
| 28 | 2017 | Kelly Culwell, M.D. Chief Medical Officer | 428.7K | 123.6K | — | — | — | 540.00 | 552.8K | 0.00% | ↗ |
| 29 | 2016 | Saundra Pelletier Chief Executive Officer | 588.5K | 201.6K | — | 1.48M | — | 1.6K | 2.27M | 65.11% | ↗ |
| 30 | 2016 | Justin J. File Chief Financial Officer | 478.1K | 163.3K | — | 822.5K | — | 1.2K | 1.47M | 56.14% | ↗ |
| 31 | 2016 | Kelly Culwell, M.D. Chief Medical Officer | 425.3K | 90.0K | — | 274.2K | — | 675.00 | 790.1K | 34.70% | ↗ |
| 32 | 2016 | George W. Mahaffey Former President and Chief Executive Officer and Director | 137.2K | — | — | — | — | 339.7K | 476.9K | 0.00% | ↗ |
| 33 | 2016 | Susan A. Knudson Former Chief Financial Officer | 281.2K | 59.1K | — | 19.2K | — | 1.0K | 360.4K | 5.32% | ↗ |
| 34 | 2016 | Maria Feldman Former Vice President, Clinical Research, Operations, Regulatory and Quality | 243.0K | 46.6K | — | 10.7K | — | 539.00 | 300.7K | 3.54% | ↗ |
| 35 | 2015 | George W. Mahaffey Former President and Chief Executive Officer and Director | 415.0K | — | — | — | — | 53.3K | 468.3K | 0.00% | ↗ |
| 36 | 2015 | Susan A. Knudson Chief Financial Officer | 275.0K | — | — | 137.7K | — | 918.00 | 413.6K | 33.29% | ↗ |
| 37 | 2015 | Lincoln A. Krochmal, M.D. Former Chief Medical Officer | 324.5K | — | — | 49.2K | — | 21.9K | 395.5K | 12.43% | ↗ |
| 38 | 2014 | George W. Mahaffey President and Chief Executive Officer and Director | 356.1K | 142.4K | 2.05M | 660.5K | — | 53.2K | 3.26M | 83.10% | ↗ |
| 39 | 2014 | George W. Mahaffey Former President and Chief Executive Officer and Director | 356.1K | 142.4K | 2.05M | 660.5K | — | 53.2K | 3.26M | 83.10% | ↗ |
| 40 | 2014 | Lincoln A. Krochmal, M.D. Former Chief Medical Officer | 315.0K | 53.6K | — | 529.8K | — | — | 898.4K | 58.98% | ↗ |
| 41 | 2014 | Lincoln A. Krochmal, M.D. Chief Medical Officer | 315.0K | 53.6K | — | 529.8K | — | — | 898.4K | 58.98% | ↗ |
| 42 | 2014 | Kenneth W. Locke, Ph.D. Chief Scientific Officer | 317.7K | 95.3K | — | 314.8K | — | 810.00 | 728.7K | 43.21% | ↗ |
| 43 | 2014 | Susan A. Knudson Chief Financial Officer | 258.8K | 80.1K | — | 155.8K | — | 8.3K | 503.0K | 30.97% | ↗ |
| 44 | 2013 | George W. Mahaffey President and Chief Executive Officer and Director | 345.9K | 121.1K | — | — | — | 40.1K | 507.0K | 0.00% | ↗ |
| 45 | 2013 | Kenneth W. Locke, Ph.D. Chief Scientific Officer | 308.6K | 61.7K | — | — | — | — | 370.3K | 0.00% | ↗ |
| 46 | 2013 | Lincoln A. Krochmal, M.D. Chief Medical Officer | 39.4K | — | — | — | — | — | 39.4K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Saundra Pelletier | Interim Chair, President & Chief Executive Officer | 803.5K | female |
| Ivy Zhang | Chief Financial Officer & Secretary | 574.6K | female |
| Amy Raskopf | Chief Business Development Officer | — | female |
| Ellen Thomas | Chief of Staff | — | female |
| Kathy Gallo-Doyle | Senior Vice President of Commercial Operations | — | female |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for EVFM
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
